Rebecca Romero, MD

• Professional Background

  Education

  • 2004 - MD - Medicine and Surgery - University of Texas Health Science Center at San Antonio
  • 2000 - BA - Biology with emphasis Chemistry & Psychology (Summa Cum Laude) - Rice University, Houston, TX

  Training

  • 2011 - Fellowship - Multiple Sclerosis/Clinical Neuroimmunology - University of Chicago, IL
  • 2008 - Residency - Neurology - University of Texas Health Science Center at San Antonio
  • 2005 - Internship - Internal Medicine - University of Texas Health Science Center at San Antonio

  Highlights

  06/2019 Texas Super Doctors
  04/2018 Fellow of the American Academy of Neurology
  02/2018 San Antonio Magazine Best Doctors in San Antonio
  09/2017 Diane Solomon MD Award for Excellence in Teaching: UT Health San Antonio, Neurology Medical Students

  Appointments

  • 2019-present - Associate Professor / Clinical - UT Health San Antonio, Department of Neurology, San Antonio, TX
  • 2018-present - Associate Residency Program Director - UT Health San Antonio, Department of Neurology, San Antonio, TX
  • 09/2011-03/2019 - Assistant Professor/Clinical - UT Health San Antonio, Department of San Antonio, San Antonio, TX

• Instruction & Training

  • 01/2011-present, 2nd Year Medical Student Lecture "Multiple Sclerosis", UT Health San Antonio

• Research & Grants

  Multiple Sclerosis and Clinical Neuroimmunology - Clinical Neuroimmunology is an ever expanding subspecialty of Neurology. Multiple Sclerosis, Neuromyelitis Optica, Autoimmune encephalitis and related diseases are increasingly recognized and discovered around the world. My focus is on the diagnosis (clinically and radiologically), treatment, and management of patients throughout their lives.

  Research profile

  Grants

  07/2016-Present
  Funding Agency: Alexion
  Title: ECU-NMO-302 A phase III, open-label, extension trial of ECU-NMO-301 to evaluate the safety and efficacy of Eculizumab in patients with relapsing Neuromyelitis Optica (NMO).
  Role: Principal Investigator

  07/2016-08/2018
  Funding Agency: Alexion
  Title: ECU-NMO-301 A Randomized, double-blind, placebo-controlled multicenter trial to evaluate the safety and efficacy of Ezulizumab in patients with relapsing Neuromyelitis Optica (NMO).
  Role: Principal Investgator

  06/2014-present
  Funding Agency: Chugai
  Title: Chugai SA-309JG NMO/NMOSD Study
  Role: Principal Investigator

• Service

  Department

  01/2018-Present Associate Residency Program Director
  09/2011-Present Director of Multiple Sclerosis and Clinical Neuroimmunology Clinic
  07/2018-Present Advising and Mentoring - Kyna Schreiber MD
  01/2017-Present Program Evaluation Committee
  07/2017-Present Advising and Mentoring - Noor Shahid MD
  07/2017-Present Advising and Mentoring - Justin Rodriguez MD PhD
  01/2016-Present Advising and Mentoring - Florence Yi Yi Ling Chang MD
  01/2014-Present Clinical Competency Committee

  National

  04/2017-Present Frontiers in Neurology Journal (Editorial Board Member)
  01/2013-Present National Multiple Sclerosis Clinical Advisory Committee (Member)
  09/2011-Present Journal of Neurological Sciences (Reviewer)
  01/2011-Present American Academy of Neurology on the Hill Attendee (Invited Participant)

• Publications

  Abstract

  Chiang FL, Romero RS, Huang SY, Yu FF, Tantiwongkosi B, Fox PT. Gray matter atrophy in multiple sclerosis: regional selectivity and connectivity 2018 Jun. (Presented at the Organization for Human Brain Mapping Conference in Singapore; vol. P, no. 1256)

  Rodriguez J, Shahid N, Romero RS. Pseudobular Affect in Multiple Sclerosis 2018 May. (Presented at UT Health San Antonio Neurology Research Day)

  Blaney H, Agarwal T, Romero RS. An Unexpected Imitator: HLH Presenting as CNS Infarction 2018 Apr. (Presented at the American Academy of Neurology Annual Meeting, Los Angeles, CA; vol. P3, no. 255)

  Fang Y, Chiang F, Stephens N, Romero RS, Huang SY, Tantiwongkosi B. Evaluation of Normal Appearing White Matter in Multiple Sclerosis using Quantitative Susceptibility Mapping and Diffusion Tensor Imagin 2017 May. (Platform Presentation at the American Society of Neuroradiology in Long Beach, CA)

  Shahid N, Romero RS. Neuromyelitis Optica Spectrum Disorder in Mexican American Patients 2017 May. (Presented at UT Health San Antonio Neurology Research Day)

  Aman AM, Romero RS. A Rare Case of Vertebral Sarcoidosis 2017 May. (Presented at UT Health San Antonio Neurology Research Day)

  Upadhyaya P, Ghodsianzadeh F, Romero RS, Bhavaraju-Sanka R. Copper Deficiency In Patients With Prior Diagnosis of ADIP 2017 Apr. (Presented at the American Academy of Neurology Annual Meeting 2017; vol. P, no. 202)

   

  Journal Article

  Chiang F, Feng M, Romero RS, Price L, Franklin C, Deng S, Gray J, Yu F, Tantiwongkosi B, Huang S, Fox P. Disruption of the Atrophy-based Functional Network in Multiple Sclerosis Is Associated with Clinical Disability: Validation of a Meta-Analytic Model in Resting-State Functional MRI Radiology 2021 Apr;299(1):159-166.

  Kotkowski E, Cabot J, Lacci J, Payne D, Cavazos J, Romero R, Seifi A, Creutzfeldt-Jakob Disease: In-hospital demographics report of national data in the United States from 2016 and review of a rapidly-progressive case Clinical Neurology and Neurosurgery 2020 Oct;197(10610)

  Chiang FL, Wang Q, Yu FF, Romero RS, Huang SY, Fox PM, Tantiwongkosi B, Fox PT. Localised grey matter atrophy in multiple sclerosis is network-based: a coordinate-based meta-analysis Clinical radiology 2019 Aug

  Yu FF, Chiang FL, Stephens N, Huang SY, Bilgic B, Tantiwongkosi B, Romero RS. Characterization of normal-appearing white matter in multiple sclerosis using quantitative susceptibility mapping in conjunction with diffusion tensor imaging. Neuroradiology 2019 Jan;61(1):71-79

  Papadopoulos K,Romero RS, Gonzalez G, Dix JE, Fury M. Anti-Hu Associated Autoimmune Limbic Encephalitis In A Patient With PD-1 Inhibitor Responsive Myxoid Chondrosarcoma The Oncologist 2018 Jan;23(1):118-120

  Coyle PK, Khatri B, Edwards KR, Meca-Lallana JE, Cavalier S, Rufi P, Benamor M, Brette S, Robinson M, Gold R, Teri-Pro Trial Group. Patient reported outcomes in relapsing forms of MS: Real World, global treatment experience with teriflunomide from the Teri-Pro study Mult Scler Relat Disord 2017 Oct;17:107-115

  Not Specified

  Chiang FL, Wang Q, Yu FF, Romero RS, Huang SY, Fox PM, Tantiwongkosi B, Fox PT. Localised grey matter atrophy in multiple sclerosis is network-based: a coordinate-based meta-analysis Clinical radiology 2019 Aug

• Clinical

  Provider profile

  Board Certifications

  • 2008 - Neurology - American Board of Psychiatry and Neurology